Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines

Christian Alvin H. Buhat (), Destiny S. M. Lutero, Yancee H. Olave, Kemuel M. Quindala, Mary Grace P. Recreo, Dylan Antonio S. J. Talabis, Monica C. Torres, Jerrold M. Tubay and Jomar F. Rabajante
Additional contact information
Christian Alvin H. Buhat: University of the Philippines Los Baños
Destiny S. M. Lutero: University of the Philippines Los Baños
Yancee H. Olave: University of the Philippines Los Baños
Kemuel M. Quindala: University of the Philippines Los Baños
Mary Grace P. Recreo: University of the Philippines Los Baños
Dylan Antonio S. J. Talabis: University of the Philippines Los Baños
Monica C. Torres: University of the Philippines Los Baños
Jerrold M. Tubay: University of the Philippines Los Baños
Jomar F. Rabajante: University of the Philippines Los Baños

Applied Health Economics and Health Policy, 2021, vol. 19, issue 5, No 7, 699-708

Abstract: Abstract Background Vaccine allocation is a national concern especially for countries such as the Philippines that have limited resources in acquiring COVID-19 vaccines. As such, certain groups are suggested to be prioritized for vaccination to protect the most vulnerable before vaccinating others. Objective The study aims to determine an optimal and equitable allocation of COVID-19 vaccines in the Philippines that will minimize the projected number of additional COVID-19 deaths while satisfying the priority groups for immediate vaccination. Methods In this study, a linear programming model is formulated to determine an allocation of vaccines such that COVID-19 deaths are minimized while the prioritization framework set by the government is satisfied. Data used were collected up to November 2020. Total vaccine supply, vaccine effectiveness, vaccine cost, and projected deaths are analyzed. Results of the model are also compared to other allocation approaches. Results Results of the model show that a vaccine coverage of around 60–70% of the population can be enough for a community with limited supplies, and an increase in vaccine supply is beneficial if the initial coverage is less than the specified target range. Additionally, among the vaccines considered in the study, the one with 89.9% effectiveness and a 183 Philippine peso price per dose projected the lowest number of deaths. Compared with other model variations and common allocation approaches, the model has achieved both an optimal and equitable allocation. Conclusions Having a 100% coverage for vaccination with a 100% effectiveness rate of vaccine is ideal for all countries. However, some countries have limited resources. Therefore, the results of our study can be used by policymakers to determine an optimal and equitable distribution of COVID-19 vaccines for a country/community.

Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://link.springer.com/10.1007/s40258-021-00667-z Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:aphecp:v:19:y:2021:i:5:d:10.1007_s40258-021-00667-z

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40258

DOI: 10.1007/s40258-021-00667-z

Access Statistics for this article

Applied Health Economics and Health Policy is currently edited by Timothy Wrightson

More articles in Applied Health Economics and Health Policy from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().